Combination treatment in stable effort angina using trimetazidine and metoprolol: Results of a randomized, double-blind, multicentre study (TRIMPOL II)

European Heart Journal

Volumn 22, Issue 24, 2001, Pages 2267-2274

  Szwed, Hanna ^a   Sadowski, Z ^a   Elikowski, W ^b   Koronkiewicz, A ^c   Mamcarz, A ^d   Orszulak, W ^e   Skibinska E ^f   Szymczak, K ^g   Swiatek J ^h   Winter, M ⁱ  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b City Hospital   (Poland)

^c PCK   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^g Voivodship Cardiological Center   (Poland)

^h Department of Cardiology   (Poland)

ⁱ Cardiological Diagn/Rehab Centre   (Poland)

Author keywords

Combination therapy; Exercise testing; Metabolic agent; Metoprolol; Stable angina; Trimetazidine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; NITRATE; PLACEBO; TRIMETAZIDINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EXERCISE TEST; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMODYNAMIC MONITORING; HUMAN; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGINA PECTORIS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EUROPE; EXERCISE TEST; FEMALE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 18244401979     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2896     Document Type: Article

References (18)

1. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions
2. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology
3. Combined beta-adrenergic and calcium entry blockade in angina pectoris
4. Characteristics of a contemporary population with angina pectoris
5. Effects of atenolol, nifedipine SR and their combination on the exercise test and total ischaemic burden in 608 patients with stable angina
6. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study
7. From antianginal drugs to myocardial cytoprotective agents
8. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions
9. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
10. Changed in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia
11. Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study
12. Trimetazidine: A new concept in the treatment of angina. Comparison with propranolol in patients with stable angina
13. Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study
14. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease Group of South of France Investigators
15. Combination treatment of trimetazidine and diltiazem in stable angina pectoris
16. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina
17. Skuteczność i tolerancja trimetazydyny jako leku wieńcowego u chorych z wysilkowa̧ dusznica̧ bolesna̧ w skojarzeniu z jednym lekiem przeciwdławicowym